This laboratory study compared the performance of four different OPEP devices, each utilizing distinctly different mechanisms to generate oscillatory pressure.
This study assessed people with COPD suffering with mucus hypersecretion, post exacerbation in Wales, UK, following treatment with a handheld, OPEP device or the ACBT breathing technique.
Depending on the pMDI/spacer system chosen the delivery of medication can vary significantly and as a result will have implications on the potential carbon footprint.
In this case, the use of the AeroChamber Plus* Flow-Vu* VHC could potentially reduce the carbon footprint by three fold compared to the alternative spacers.
By maximizing the amount of each puff reaching the lungs the patient is likely to be able to get relief sooner and reduce the amount of puffs needed.
Depending on the pMDI/spacer system chosen the delivery of medication can vary significantly and as a result will have implications on the potential carbon footprint.
In this case, the use of the AeroChamber Plus* Flow-Vu* VHC could potentially reduce the carbon footprint by three fold compared to the alternative spacers.
By maximizing the amount of each puff reaching the lungs the patient is likely to be able to get relief sooner and reduce the amount of puffs needed.
Does Spacer/Adapter Device Choice Affect Delivery of a Pressurized Metered Dose Inhaler (pMDI) through a Humidified Circuit to a Simulated Patient on Mecha
The widely differing inspiratory flow profiles from Turbuhaler† DPI contributed to greater variability in delivered dose to the carina.
MDI delivery via the AeroChamber Plus* Flow-Vu* VHC resulted in significantly increased mass to the carinal region irrespective of inhalation maneuver as well as reduced oropharyngeal deposited mass which in vivo is likely to result in reduced throat irritation or thrush in the mouth and throat.
This laboratory and clinical overview demonstrates appreciable differences in pressure pulse waveforms for differing OPEP devices and then links these for the leading laboratory performing device into reported airway physiological changes and improved clinical outcomes.
New information regarding the efficiency and effectiveness of different oscillating positive expiratory pressure devices was presented at CHEST 2017 in Toronto, Canada.
La prise en charge de votre asthme est plus importante que jamais. Par conséquent, nous aimerions vous inviter à vous joindre à Stéphane Côté qui discutera de ce qui suit :
Meilleure façon de prendre en charge votre asthme (ou celui de votre enfant)
Comment maîtriser l’asthme
Utilisation de médicaments inhalés et rôle des chambres d’inhalation
Nouveautés Loi 31 – Enfin! Mais comment faire mieux avec nos patients en santé respiratoire?
L’ajout récent des prises en charge pour l’asthme et la MPOC dans les actes de la Loi 31 est une opportunité intéressante et rentable d’améliorer la santé respiratoire des patients. Ce webinaire vous permettra de mettre à jour vos connaissances en santé respiratoire, d’obtenir des outils pratiques afin de réaliser ces actes dans vos pharmacies et d’apprivoiser leur facturation. Un événement à ne pas manquer!
